MX2014001855A - Nuevo compuesto aislado de quamoclit, y una composicion para la prevencion o el tratamiento de la diabetes que contiene el compuesto como un ingrediente activo. - Google Patents
Nuevo compuesto aislado de quamoclit, y una composicion para la prevencion o el tratamiento de la diabetes que contiene el compuesto como un ingrediente activo.Info
- Publication number
- MX2014001855A MX2014001855A MX2014001855A MX2014001855A MX2014001855A MX 2014001855 A MX2014001855 A MX 2014001855A MX 2014001855 A MX2014001855 A MX 2014001855A MX 2014001855 A MX2014001855 A MX 2014001855A MX 2014001855 A MX2014001855 A MX 2014001855A
- Authority
- MX
- Mexico
- Prior art keywords
- quamoclit
- compound
- preventing
- active ingredient
- composition
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 7
- 239000004480 active ingredient Substances 0.000 title abstract 3
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 208000002249 Diabetes Complications Diseases 0.000 abstract 3
- 206010012655 Diabetic complications Diseases 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 abstract 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000003914 insulin secretion Effects 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
- C07H1/08—Separation; Purification from natural products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Ophthalmology & Optometry (AREA)
- Polymers & Plastics (AREA)
- Genetics & Genomics (AREA)
- Physical Education & Sports Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Crystallography & Structural Chemistry (AREA)
- Food Science & Technology (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
Abstract
La presente invención se refiere a un nuevo compuesto aislado de Quamoclit sp., y más particularmente a un nuevo compuesto aislado de Quamoclit sp. y una composición para prevenir o tratar la diabetes y sus complicaciones que comprende el compuesto como un ingrediente activo. El nuevo compuesto aislado de Quamoclit sp. de acuerdo a la presente invención tiene excelentes efectos en la disminución de azúcar en sangre, promoviendo la secreción de insulina, inhibición de la expresión de VEGF, etc. Es decir, la presente invención no solo funciona para prevenir o tratar la diabetes y sus complicaciones, sino también funciona para promover los efectos del tratamiento cuando son tratados junto con medicamentos convencionales para diabetes.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20110082445 | 2011-08-18 | ||
KR1020120064524A KR101550390B1 (ko) | 2011-08-18 | 2012-06-15 | 유홍초속에서 분리한 신규화합물 및 이를 유효성분으로 포함하는 당뇨병의 예방 또는 치료용 조성물 |
PCT/KR2012/005129 WO2013024968A1 (ko) | 2011-08-18 | 2012-06-28 | 유홍초속에서 분리한 신규화합물 및 이를 유효성분으로 포함하는 당뇨병의 예방 또는 치료용 조성물 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2014001855A true MX2014001855A (es) | 2015-04-16 |
Family
ID=47898461
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014001855A MX2014001855A (es) | 2011-08-18 | 2012-06-28 | Nuevo compuesto aislado de quamoclit, y una composicion para la prevencion o el tratamiento de la diabetes que contiene el compuesto como un ingrediente activo. |
Country Status (9)
Country | Link |
---|---|
US (1) | US9487596B2 (es) |
EP (1) | EP2746280B1 (es) |
JP (1) | JP5973571B2 (es) |
KR (1) | KR101550390B1 (es) |
AU (1) | AU2012295728A1 (es) |
BR (1) | BR112014003759A2 (es) |
CA (1) | CA2845496A1 (es) |
MX (1) | MX2014001855A (es) |
WO (1) | WO2013024968A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105473565A (zh) * | 2013-05-24 | 2016-04-06 | 韩国生命工学研究院 | 茑萝属植物来源新化合物及包含其为有效成分的糖尿病的预防或治疗用组合物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3830960B1 (ja) * | 2005-08-12 | 2006-10-11 | 建仁 河乃 | 育毛物質 |
KR100988510B1 (ko) * | 2005-10-17 | 2010-10-20 | 이행우 | 제 2형 당뇨의 예방용 조성물 및 이를 포함하는 건강보조 식품 |
US20130004596A1 (en) * | 2010-02-19 | 2013-01-03 | Korea Research Institute Of Bioscience And Biotechnology | Pharmaceutical composition for treating diabetes containing quamoclit angulata extract |
KR20130020623A (ko) * | 2011-08-17 | 2013-02-27 | 한국생명공학연구원 | 유홍초 추출물을 함유하는 당뇨합병증 예방 또는 치료용 조성물 |
KR101605343B1 (ko) * | 2011-08-17 | 2016-03-22 | 주식회사 나노바이오텍 | 유홍초 추출물 또는 유홍초 유래 화합물을 함유하는 항암 또는 항산화 조성물 |
-
2012
- 2012-06-15 KR KR1020120064524A patent/KR101550390B1/ko active IP Right Grant
- 2012-06-28 CA CA2845496A patent/CA2845496A1/en not_active Abandoned
- 2012-06-28 JP JP2014525914A patent/JP5973571B2/ja active Active
- 2012-06-28 US US14/239,136 patent/US9487596B2/en active Active
- 2012-06-28 MX MX2014001855A patent/MX2014001855A/es not_active Application Discontinuation
- 2012-06-28 WO PCT/KR2012/005129 patent/WO2013024968A1/ko active Application Filing
- 2012-06-28 BR BR112014003759-0A patent/BR112014003759A2/pt not_active IP Right Cessation
- 2012-06-28 AU AU2012295728A patent/AU2012295728A1/en not_active Abandoned
- 2012-06-28 EP EP12824562.8A patent/EP2746280B1/en not_active Not-in-force
Also Published As
Publication number | Publication date |
---|---|
KR101550390B1 (ko) | 2015-09-08 |
EP2746280B1 (en) | 2016-05-25 |
EP2746280A1 (en) | 2014-06-25 |
US9487596B2 (en) | 2016-11-08 |
BR112014003759A2 (pt) | 2017-06-13 |
CA2845496A1 (en) | 2013-02-21 |
CN104125958A (zh) | 2014-10-29 |
KR20130020544A (ko) | 2013-02-27 |
JP2014524494A (ja) | 2014-09-22 |
JP5973571B2 (ja) | 2016-08-23 |
EP2746280A4 (en) | 2015-01-14 |
WO2013024968A1 (ko) | 2013-02-21 |
US20140179622A1 (en) | 2014-06-26 |
AU2012295728A1 (en) | 2014-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018500767A1 (en) | Pharmaceutical composition, methods for treating and uses thereof | |
PH12018501424B1 (en) | A composition for treating diabetes or diabesity comprising oxyntomodulin analog | |
EA201991014A1 (ru) | Лечение диабета | |
EA201300522A1 (ru) | Фармацевтические комбинации для лечения метаболических нарушений | |
GB2491327A (en) | Delayed prolonged drug delivery | |
GB2476202A (en) | Novel choline cocrystal of epalrestat | |
EA201490377A1 (ru) | Лечение рассеянного склероза комбинацией лаквинимода и глатирамера ацетата | |
GB2491328A (en) | Immediate/delayed drug delivery | |
EA201390409A1 (ru) | Составы с низкой дозой панкрелипазы и кишечно-растворимым покрытием | |
MY152172A (en) | Therapeutic agent for diabetes | |
GEP20196969B (en) | New therapeutical composition containing apomorphine as active ingredient | |
EP2490700A4 (en) | EXTERNAL SKIN CARE COMPOSITION COMPRISING SALT AND SUGAR AS ACTIVE INGREDIENTS FOR PREVENTING AND TREATING VAGINOSIS AND USE THEREOF | |
PH12014502448A1 (en) | Pharmaceutical combinations for the treatment of metabolic disorders | |
EA201201617A1 (ru) | Применение метморфина в комбинации с активатором глюкокиназы и композиции, содержащие метморфин и активатор глюкокиназы | |
AU2009246603A8 (en) | Von willebrand factor (vwf) inhibitors for treatment or prevention of infarction | |
EA201590051A1 (ru) | Новое соединение, обладающее способностью ингибировать фермент 11бета-hsd1, или его фармацевтически приемлемая соль, способ его получения и фармацевтическая композиция, содержащая такое соединение в качестве активного ингредиента | |
MX2013002208A (es) | Derivados de sulfonilpiperazina que interactuan con la proteina reguladora de glucocinasa para el tratamiento de diabetes. | |
EA201391063A1 (ru) | Аполипопротеин a-iv в качестве антидиабетического пептида | |
ZA202310748B (en) | Pharmaceutical composition for preventing or treating diabetes mellitus in animal of family canidae, comprising enavogliflozin | |
PH12017502145A1 (en) | Composition and uses thereof | |
MX2014001855A (es) | Nuevo compuesto aislado de quamoclit, y una composicion para la prevencion o el tratamiento de la diabetes que contiene el compuesto como un ingrediente activo. | |
MX2020009271A (es) | Composiciones y métodos para el tratamiento de la resistencia a la insulina. | |
WO2012047628A3 (en) | Methods of managing blood sugar levels and compositions related thereto | |
MX2013011561A (es) | Compuestos de benzodioxepina y benzodioxina que interactuan con la proteina reguladora de glucocinasa para el tratamiento de diabetes. | |
WO2011152658A3 (en) | Pharmaceutical composition comprising piperazine dithioctate and glimepiride |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |